Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0000875320-24-000214 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | 2024-10-02 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $461.66 | -999 | 16.7K | -6% | -$461.2K | |
| 2024-10-03 | 2024-10-01 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $466.84 | -630 | 17.6K | -3% | -$294.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-02 | S | D | 999 | $461.66 | 16,651 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-01 | F | D | 630 | $466.84 | 17,650 | D | — | — |